Publication | Open Access
Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia
24
Citations
65
References
2022
Year
ClinicalTrials.gov NCT03371706 . Registered prospectively on December 13, 2017.
| Year | Citations | |
|---|---|---|
Page 1
Page 1